Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1981 Aug;68(2):491–496. doi: 10.1172/JCI110280

Sequential treatments of premature lambs with an artificial surfactant and natural surfactant.

M Ikegami, A Jobe, H Jacobs, S J Jones
PMCID: PMC370823  PMID: 6790576

Abstract

To test an artificial surfactant in vivo, six 120-d gestational age lambs were treated at birth with a mixture of a 9:1 M ratio of [14C]dipalmitoyl phosphatidylcholine (DPC) and phosphatidylglycerol at a dose of 100 mg DPC/kg. Nine other lambs were not treated. The mean PO2 values of the lambs treated with artificial surfactant were 65.7 +/- 11 mm Hg vs. 24.8 +/- 1.6 mm Hg for the untreated lambs (P less than 0.001). All lambs then were treated with 50 mg/natural surfactant lipid per kg, which promptly improved PO2 in all lambs. The PO2 values of those lambs previously treated with artificial surfactant remained greater than 100 mm Hg for 2.5 +/- 0.5 h vs. 0.9 +/- 0.3 h for lambs untreated with artificial surfactant (P less than 0.01). The pH and PCO2 values were not strikingly different between the two groups of lambs. Airway samples taken from lambs treated with artificial surfactant before treatment with natural surfactant had minimal surface tensions of 32 +/- 2.9 dyn/cm, whereas the artificial surfactant reisolated from these samples by centrifugation had minimum surface tension of 0 dyn/cm. The minimum surface tension of artificial surfactant was inhibited by fetal lung fluid from the premature lambs, whereas the minimum surface tension of natural surfactant was much less sensitive to inhibition. Artificial surfactant did not improve the pressure-volume characteristics of unventilated premature lung, whereas natural surfactant did. The change in specific activity of [14C]DPC following treatment with natural surfactant indicated that approximately 50% of the DPC initially administered was no longer associated with the airways.

Full text

PDF
491

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADAMS F. H., FUJIWARA T., EMMANOUILIDES G., SCUDDER A. SURFACE PROPERTIES AND LIPIDS FROM LUNGS OF INFANTS WITH HYALINE MEMBRANE DISEASE. J Pediatr. 1965 Feb;66:357–364. doi: 10.1016/s0022-3476(65)80193-7. [DOI] [PubMed] [Google Scholar]
  2. AVERY M. E., MEAD J. Surface properties in relation to atelectasis and hyaline membrane disease. AMA J Dis Child. 1959 May;97(5 Pt 1):517–523. doi: 10.1001/archpedi.1959.02070010519001. [DOI] [PubMed] [Google Scholar]
  3. Adams F. H., Towers B., Osher A. B., Ikegami M., Fujiwara T., Nozaki M. Effects of tracheal instillation of natural surfactant in premature lambs. I. Clinical and autopsy findings. Pediatr Res. 1978 Aug;12(8):841–848. doi: 10.1203/00006450-197808000-00008. [DOI] [PubMed] [Google Scholar]
  4. BARTLETT G. R. Phosphorus assay in column chromatography. J Biol Chem. 1959 Mar;234(3):466–468. [PubMed] [Google Scholar]
  5. Chu J., Clements J. A., Cotton E. K., Klaus M. H., Sweet A. Y., Tooley W. H., Bradley B. L., Brandorff L. C. Neonatal pulmonary ischemia. I. Clinical and physiological studies. Pediatrics. 1967 Oct;40(4 Suppl):709–782. [PubMed] [Google Scholar]
  6. Fujiwara T., Adams F. H. Surfactant for hyaline membrane disease. Pediatrics. 1980 Nov;66(5):795–798. [PubMed] [Google Scholar]
  7. Fujiwara T., Maeta H., Chida S., Morita T., Watabe Y., Abe T. Artificial surfactant therapy in hyaline-membrane disease. Lancet. 1980 Jan 12;1(8159):55–59. doi: 10.1016/s0140-6736(80)90489-4. [DOI] [PubMed] [Google Scholar]
  8. Hallman M., Gluck L. Phosphatidylglycerol in lung surfactant. III. Possible modifier of surfactant function. J Lipid Res. 1976 May;17(3):257–262. [PubMed] [Google Scholar]
  9. Ikegami M., Hesterberg T., Nozaki M., Adams F. H. Restoration of lung pressure-volume characteristics with surfactant: comparison of nebulization versus instillation and natural versus synthetic surfactant. Pediatr Res. 1977 Mar;11(3 Pt 1):178–182. doi: 10.1203/00006450-197703000-00007. [DOI] [PubMed] [Google Scholar]
  10. Ikegami M., Silverman J., Adams F. H. Restoration of lung pressure-volume characteristics with various phospholipids. Pediatr Res. 1979 Jun;13(6):777–780. doi: 10.1203/00006450-197906000-00012. [DOI] [PubMed] [Google Scholar]
  11. Jobe A., Ikegami M., Glatz T., Yoshida Y., Diakomanolis E., Padbury J. Duration and characteristics of treatment of premature lambs with natural surfactant. J Clin Invest. 1981 Feb;67(2):370–375. doi: 10.1172/JCI110044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jobe A., Kirkpatrick E., Gluck L. Labeling of phospholipids in the surfactant and subcellular fractions of rabbit lung. J Biol Chem. 1978 Jun 10;253(11):3810–3816. [PubMed] [Google Scholar]
  13. Mason R. J., Nellenbogen J., Clements J. A. Isolation of disaturated phosphatidylcholine with osmium tetroxide. J Lipid Res. 1976 May;17(3):281–284. [PubMed] [Google Scholar]
  14. Morley C. J., Bangham A. D., Miller N., Davis J. A. Dry artificial lung surfactant and its effect on very premature babies. Lancet. 1981 Jan 10;1(8211):64–68. doi: 10.1016/s0140-6736(81)90002-7. [DOI] [PubMed] [Google Scholar]
  15. Morley C., Robertson B., Lachmann B., Nilsson R., Bangham A., Grossmann G., Miller N. Artificial surfactant and natural surfactant. Comparative study of the effects on premature rabbit lungs. Arch Dis Child. 1980 Oct;55(10):758–765. doi: 10.1136/adc.55.10.758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nozaki M. Pressure-volume relationship of a model alveolus. Tohoku J Exp Med. 1970 Jul;101(3):271–279. doi: 10.1620/tjem.101.271. [DOI] [PubMed] [Google Scholar]
  17. Oyarzún M. J., Clements J. A., Baritussio A. Ventilation enhances pulmonary alveolar clearance of radioactive dipalmitoyl phosphatidylcholine in liposomes. Am Rev Respir Dis. 1980 Apr;121(4):709–721. doi: 10.1164/arrd.1980.121.4.709. [DOI] [PubMed] [Google Scholar]
  18. Shannon D. C., Kazemi H., Merrill E. W., Smith K. A., Wong P. S. Restoration of volume-pressure curves with a lecithin fog. J Appl Physiol. 1970 Apr;28(4):470–473. doi: 10.1152/jappl.1970.28.4.470. [DOI] [PubMed] [Google Scholar]
  19. Van Golde L. M. Metabolism of phospholipids in the lung. Am Rev Respir Dis. 1976 Nov;114(5):977–1000. doi: 10.1164/arrd.1976.114.5.977. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES